analysis of CMS-2025-1823-0001
CMS-2025-1823: Analysis of Proposed Federal Medicaid/CHIP Prohibition on Gender-Affirming Care for Minors
Overview
| Field | Detail |
|---|---|
| Docket ID | CMS-2025-1823 |
| Rule Citation | CMS-2451-P (RIN 0938-AV73) |
| Agency | Centers for Medicare & Medicaid Services (CMS), U.S. Department of Health and Human Services |
| Docket Type | Rulemaking — Proposed Rule |
| Document Count | 1 (Proposed Rule, posted December 19, 2025) |
| Comment Period | December 19, 2025 – February 18, 2026 (61 days) |
| Total Comments | 11,410 |
| Attachments | 30 comments include formal PDF attachments |
| Last Modified | January 14, 2026 |
The sole document in the docket is the proposed rule, published December 19, 2025. It received 11,410 public comments across the comment period, representing one of the largest comment volumes in recent CMS rulemaking history for a single proposed rule.
Summary
CMS-2025-1823 proposes to prohibit federal Medicaid and CHIP funding for what the rule terms "sex-rejecting procedures" (SRPs) furnished to individuals under 18 (Medicaid) and under 19 (CHIP). The rule would require state Medicaid and CHIP plans to affirmatively certify non-payment for these procedures as a condition of receiving federal matching funds. The proposed rule is closely related to a companion rule, CMS-3481-P, which addresses hospital Conditions of Participation — meaning hospitals that provide such care to any patient could risk losing their entire Medicaid and Medicare funding.
The rule originates from executive policy priorities of the Trump administration aimed at restricting gender transition-related medical interventions for minors using federal program funds. The agency employs the non-standard term "sex-rejecting procedures" in lieu of the clinically recognized term "gender-affirming care," a framing widely criticized by medical professionals as scientifically inaccurate and politically motivated.
The rule's significance is substantial: Medicaid and CHIP cover approximately 50% of all U.S. children. Its practical effect would be a near-total ban on access to gender-affirming care for low-income youth, given that private insurance coverage would remain available only to those with means. The rule also implicates federal trust obligations to Native American tribes, as over 50% of Indigenous children are covered by Medicaid or CHIP.
Document Analysis
CMS-2025-1823-0001 — Proposed Rule (Posted December 19, 2025)
This is the sole agency document in the docket. Key provisions include:
- Medicaid prohibition: Requires state Medicaid plans to certify they will not make payment for SRPs for individuals under 18.
- CHIP prohibition: Requires separate CHIP plans to certify non-payment for SRPs for individuals under 19, notably extending the age threshold to include legal adults aged 18.
- Enforcement mechanism: Compliance is tied to participation conditions, with non-compliant states or hospitals potentially at risk of losing federal Medicaid/Medicare funding. The companion rule (CMS-3481-P) extends this to hospital Conditions of Participation.
- Terminology: The rule coins the term "sex-rejecting procedures," which does not appear in peer-reviewed medical literature or standard medical coding systems (ICD, CPT). Commenters note it does not appear in PubMed searches.
- Scope: The rule does not define exceptions for intersex youth or differentiate between reversible treatments (e.g., GnRH agonists/puberty blockers) and irreversible surgical procedures.
- Underlying basis: The rule references an HHS evidence review whose methodology was widely challenged in comments as selectively applying evidentiary standards.
The file URL for the proposed rule is not publicly linked in the docket record, though the rule was published in the Federal Register.
Comment Analysis
Volume and Timing
- Total comments: 11,410 across a 61-day comment window
- Daily average: approximately 187 comments/day
- Comment period: December 19, 2025 – February 18, 2026
Comments were analyzed across 23 batches of approximately 500 each (final batch: 410). The distribution across batches is consistent, suggesting sustained public engagement throughout the period rather than a single surge event.
Organized Advocacy Patterns
Multiple coordinated campaigns are evident:
- Tribal sovereignty template (~1,200–1,500 estimated total occurrences across batches): Near-identical comments invoking federal trust/treaty obligations to Native Americans and noting that over 50% of Indigenous children use Medicaid/CHIP. Likely coordinated through tribal advocacy coalitions and Indigenous rights organizations.
- Equality California transmission: Hundreds of comments submitted on behalf of individual signatories through a formal submission infrastructure, particularly concentrated in Batches 1–10. These bear headers identifying the transmitting organization.
- Opposition form letter ("sex-rejecting procedures / protect children"): Appearing predominantly in Batches 11–18, a template supporting the proposed rule with boilerplate language about child protection, mutilation, and taxpayer concerns.
- Silver State Equality: Identified as a secondary submission conduit in Batch 21.
Despite heavy template usage, a substantial portion of comments — particularly from healthcare professionals, parents, and transgender individuals — are original, substantive, and individually authored.
Sentiment & Stance
Aggregate Stance Distribution (11,410 comments)
Based on per-batch analysis synthesized across all 23 batches:
| Stance | Estimated Count | Estimated % |
|---|---|---|
| Oppose Rule (support access to care) | ~9,800 | ~86% |
| Support Rule (restrict/prohibit access) | ~900 | ~8% |
| Neutral / Other / Incomplete | ~710 | ~6% |
Note: Batches 1–10 and 19–20 showed opposition rates of 95–99%. Batches 11–18 and 21–22 showed higher support rates (15–35%) reflecting the arrival of organized pro-rule campaign comments in that portion of the docket. The overall ratio remains overwhelmingly oppositional.
Key Arguments — Opposition to Rule (~9,800 comments)
Medical necessity and evidence-based care (~2,800 comments): Gender-affirming care is endorsed by the American Medical Association, American Academy of Pediatrics, American Psychological Association, American College of Obstetricians and Gynecologists, Endocrine Society, WPATH, and WHO. The rule contradicts established standards of care.
Suicide prevention and mental health (~2,400 comments): Research consistently cited shows 50–86% of transgender youth without care experience suicidal ideation. Studies demonstrate 60–73% reductions in depression and suicidality with access to gender-affirming care (Trevor Project data, Austin et al., and other peer-reviewed research cited extensively).
Government overreach and medical autonomy (~1,800 comments): Healthcare decisions belong to patients, families, and physicians — not federal agencies. The rule substitutes political judgment for clinical judgment.
Equity and access for low-income youth (~1,400 comments): Medicaid/CHIP restrictions create a two-tiered system in which only wealthy families can access care privately. The rule targets the most vulnerable by design.
Tribal sovereignty and federal trust obligations (~1,200–1,500 comments): Over 50% of Indigenous children are insured through Medicaid/CHIP; the rule disproportionately harms Native youth and violates federal treaty and trust obligations.
Personal testimony (~1,100 comments): Parents, transgender individuals, and healthcare workers describe life-saving outcomes from gender-affirming care and predict deaths from restriction.
Terminology objection (~600 comments): "Sex-rejecting procedures" is not a recognized medical term, does not appear in PubMed, and is characterized as inflammatory, politically motivated language designed to stigmatize standard medical care.
Reversibility of treatments (~500 comments): Puberty blockers (GnRH agonists) are reversible, have been used safely in pediatric endocrinology for decades (including for precocious puberty in cisgender youth), and are distinct from surgical interventions, which are rare for minors.
Legal and constitutional concerns (~400 comments): Arguments invoking ACA Section 1557 nondiscrimination provisions, the 14th Amendment's Equal Protection Clause, Social Security Act Section 1801 (prohibition on federal interference in medical practice), and Administrative Procedure Act challenges to CMS authority.
Methodological critique of HHS review (~200 comments): The underlying HHS evidence review is criticized for asymmetric evidentiary standards — treating mixed findings as cautionary signals while dismissing positive findings as insufficiently rigorous.
Key Arguments — Support for Rule (~900 comments)
Child protection / maturity concerns (~400 comments): Children and adolescents lack the developmental capacity to consent to irreversible medical decisions; the prefrontal cortex continues developing into the mid-20s.
Irreversibility and long-term harms (~350 comments): Puberty blockers cause bone density loss; hormones affect fertility; surgeries are permanent. Claims of infertility, sexual dysfunction, and cardiovascular risks.
Insufficient long-term evidence (~280 comments): Limited randomized controlled trial data; regret rates understated; the Cass Review (UK) cited as cautionary evidence.
Religious/moral objections (~200 comments): Arguments grounded in the immutability of biological sex, divine creation ("God doesn't make mistakes"), and moral opposition to transition-related interventions.
Taxpayer concerns (~180 comments): Public funds should not support what supporters characterize as elective or harmful procedures.
Preference for psychological intervention (~150 comments): Counseling and therapy should address the root causes of gender dysphoria before or instead of medical intervention.
Detransition/regret narratives (~100 comments): References to lawsuits, de-transitioner accounts, and claims of higher-than-reported regret rates.
Key Themes
The following themes recur with sufficient frequency and consistency across all 23 batches to be treated as primary analytical categories:
1. Life-or-Death Framing The single most dominant rhetorical frame in the docket. Opponents consistently characterize the rule as a death sentence for vulnerable youth, citing suicide statistics. Phrases such as "gender-affirming care saves lives," "children will die," and "gender-affirming care is suicide prevention" appear in hundreds of variations. This framing is backed by specific research citations across a substantial portion of comments.
2. Medical Consensus vs. Government Authority A structural tension pervades the entire docket: virtually all major U.S. and international medical organizations support gender-affirming care as evidence-based medicine, while the federal rule contradicts this consensus. Commenters — including numerous licensed physicians, psychiatrists, and therapists — frame this as an unprecedented intrusion of government ideology into clinical medicine.
3. Equity and Class-Based Discrimination The Medicaid/CHIP mechanism is widely identified as the crux of the rule's discriminatory impact: wealthy families can access care through private insurance while low-income families cannot. This is characterized not as a side effect but as the operative design of the rule.
4. Tribal Sovereignty and Indigenous Rights A large, coordinated bloc of comments focuses exclusively on the disproportionate harm to Indigenous youth, the violation of federal trust and treaty obligations, the spiritual significance of Two-Spirit traditions, and the impropriety of applying this rule to tribal health programs. This theme is quantitatively the single largest template campaign in the docket.
5. Terminology as Policy Signal The rule's coinage of "sex-rejecting procedures" is treated by hundreds of commenters as evidence of the rule's ideological rather than scientific basis. Commenters note the term appears in no medical literature, no clinical coding system, and no professional society guidance. This is framed as CMS itself rejecting medical expertise in favor of political framing.
6. Government Overreach / Medical Autonomy The physician-patient-family relationship is consistently invoked as the appropriate locus of medical decision-making. Commenters across stakeholder categories argue that federal agencies should not substitute their judgment for that of trained clinicians and informed families.
7. Hospital Conditions of Participation Coercion A subset of legally sophisticated comments (particularly in organizational submissions) highlight the companion rule's threat to withdraw all Medicaid/Medicare funding from any hospital that provides gender-affirming care — a mechanism commenters characterize as coercive, disproportionate, and potentially threatening to entire hospital systems serving vulnerable populations.
8. Reversibility Distinctions Opponents of the rule consistently distinguish between reversible interventions (puberty blockers, early hormone therapy) and irreversible surgical procedures, noting that surgery is extremely rare for minors and that the rule fails to draw these distinctions. Supporters dispute the reversibility claims, particularly regarding puberty blockers.
9. Age 18-19 Extension The CHIP provision extending the prohibition to age 19 (covering legal adults) draws specific criticism as an unusual and unjustifiable extension of a "children's" protection rationale to adults with full legal capacity.
10. International Comparative Evidence Both sides invoke international precedent. Opponents of the rule cite increased suicides following restrictions in the UK after the Cass Review and argue that most developed nations maintain access. Supporters cite the Cass Review and similar reviews in Sweden and Finland as cautionary signals about evidence quality.
Attachment Analysis
Thirty comments include formal PDF attachments. Based on attachment titles, these fall into the following categories:
Formal Legal and Policy Comment Letters (majority of attachments) Most attachments are formal organizational comment letters submitted under the standard regulatory comment format. Identified submitting organizations include:
- Oregon Health Authority (CMS-2025-1823-10023): State agency formal comment, likely opposing the rule given Oregon's established state-level protections.
- California Hospital Association / CAHP (CMS-2025-1823-10037): Hospital industry comment; title suggests concern about hospital funding implications.
- Legal Aid Society (CMS-2025-1823-10072): Civil legal services organization; title suggests focus on access/equity/constitutional issues.
- Garden State Equality (CMS-2025-1823-10080): New Jersey LGBTQ+ advocacy organization formal comment on Medicaid/CHIP funding.
- New York Civil Liberties Union (NYCLU) (CMS-2025-1823-10124): Civil liberties legal organization; likely raises constitutional/civil rights objections.
- American Foundation for Suicide Prevention (AFSP) (CMS-2025-1823-10127): Major suicide prevention organization; likely opposes rule based on mental health/suicide risk evidence.
- Planned Parenthood Federation of America (PPFA) (CMS-2025-1823-10131): Reproductive health organization; formal comments on gender-affirming care coverage.
- Equality Virginia (CMS-2025-1823-10133): State LGBTQ+ advocacy organization formal comment.
- Equality California / EQCA (CMS-2025-1823-10132): Major California LGBTQ+ organization that also served as a comment transmission conduit throughout the docket.
- Communications Workers of America (CWA) (CMS-2025-1823-10102): Labor union comment, suggesting worker/healthcare worker perspective.
- California Primary Care Association (CPCA) (CMS-2025-1823-10146): Primary care provider network; likely raises access/delivery concerns.
- PRH, ACN, and NAF (CMS-2025-1823-10142): Reproductive health organizations submitting joint comment on both CMS-2451-P and CMS-3481-P.
- QLaw/LV and NoHLA (CMS-2025-1823-10143): Legal organizations; likely constitutional/civil rights analysis.
- Mental Health Policy Association (MHPA) (CMS-2025-1823-10047): Mental health policy organization; likely raises suicide prevention/mental health evidence.
- Center for Children, Youth, and Justice (CCYJ) (CMS-2025-1823-10041): Youth-focused policy organization; two documents submitted.
- Joint Comment (2026-02-17) (CMS-2025-1823-10121): Coalition comment from multiple organizations; likely a coordinated multi-organization submission filed at the close of the comment period.
- DNH comment (CMS-2025-1823-10061): Organization identity unclear from title alone.
Individual/Personal Submissions Several attachments are identified as personal comments (CMS-2025-1823-10029, 10043, 10067, 10083, 10091), suggesting individuals who chose to submit detailed personal statements as attached documents rather than inline text.
Position Statements / Clinical Guidelines CMS-2025-1823-10134 includes two attachments: "Position-Gender-Affirming-Care-Transgender-Youth" and "transgender-nonbinary-inclusive-care," suggesting a clinical or professional organization submitting its formal position statement and care guidelines.
Image Attachments Two comments (CMS-2025-1823-10118, 10132) include image files, likely infographics, charts, or photographs submitted alongside text comments.
Key Substantive Findings from Attachment Titles The attachment record indicates that the most sophisticated legal, medical, and policy challenges to the rule were filed as formal PDF documents by established organizations. The presence of the AFSP, NYCLU, Legal Aid Society, state government agencies, hospital associations, labor unions, and multiple LGBTQ+ legal organizations signals that the rule faces opposition from a broad institutional coalition spanning public health, civil liberties, healthcare delivery, and labor sectors. The filing of joint organizational comments on the final day of the comment period (February 17–18, 2026) is consistent with organized coalition advocacy.
Note: Full text of attached PDFs was not available in the batch analysis data. The above analysis is based on document titles and submitting organization identities.
Representative Quotes
Opposition to Rule (Support Access to Care)
Medical professionals:
"This rule is based on a lie. There is in fact a preponderance of conclusive medical evidence..." — CMS-2025-1823-8409
"As a psychiatrist...Medicaid should not get in the way of a child and their doctors. Medical professionals can decide what the best treatment option is." — CMS-2025-1823-6094
"I am a physician who has taken care of trans youth...Preventing trans youth from receiving the care they need will make people less healthy." — CMS-2025-1823-0885
"As a physician, I am appalled by this measure. Data is clear that gender affirming care saves lives of children." — CMS-2025-1823-1603
Parents of transgender youth:
"I am the parent of a transgender daughter who is alive today because she had access to medically necessary, gender-affirming health care. Before she received care, we were losing her." — CMS-2025-1823-8670 (and batch 3 equivalents)
"Without gender affirming care, there is no doubt in my mind that my son would be dead." — CMS-2025-1823-1564
"My child is trans and has known who he is for several years. Now that he is entering puberty, he has been receiving hormone treatment. This treatment has been critical to his identity and happiness." — CMS-2025-1823-3099
Transgender individuals:
"Gender affirming care saved my life, and I would not be the stable, functional member of society that I am today without it." — CMS-2025-1823-7877
"I'm 15 and transgender and I really don't want to lose HRT. I'm scared please don't let this pass." — CMS-2025-1823-6461
"I am a transgender woman whose life has been profoundly and positively transformed by access to evidence-based gender affirming medical care. Before receiving gender-affirming care, I experienced severe mental health challenges, including suicidality." — CMS-2025-1823-0252
On government overreach:
"When an individual experiences gender dysphoria, a course of action or treatment should be decided upon on an individual basis, according to the individual situation, in consult with the person, their doctor, and their family. The government has no place in this private medical decision." — CMS-2025-1823-6613
"Making medical providers choose between keeping their federal funding or helping give access to life-saving procedures is morally wrong and disgraceful." — CMS-2025-1823-5978
On equity:
"This is a direct attack not only on trans youth but specifically low-income trans youth." — CMS-2025-1823-10705
On terminology:
"Sex-rejecting procedures is not a medical term and does not appear in PubMed...It is a poorly designed phrase." — CMS-2025-1823-0771
On evidence:
"The asymmetry in interpreting the evidence...treats null or mixed findings as cautionary signals, while positive findings are dismissed as insufficiently rigorous." — CMS-2025-1823-8248
"Trans youth with access to gender-affirming care experience drastically reduced depression rates...regret rates less than 1%—lower than knee surgery." — CMS-2025-1823-10576
Support for Rule (Support Funding Prohibition)
"Sex-denying medical interventions cause lasting harm, including infertility and lifelong medical complications." — CMS-2025-1823-7418
"No child needs puberty blockers...It's experimental, ideology-driven abuse with weak evidence of benefit and clear risks." — CMS-2025-1823-2936
"Mutilating children's bodies is not healthcare; it's a disgrace to our Creator." — CMS-2025-1823-3439
"Medicaid funds should never be used to mutilate children's bodies." — Multiple comments (4414, 4515, 5518)
"Treating a mental condition like gender dysphoria with cross-sex hormones and irreversible surgery has not been shown to be safe or effective long term. See the UK's Cass Report for evidence." — CMS-2025-1823-0377
"I am a board-certified physician...The adoption of this rule is critical to protecting minors from medications and surgeries that carry lifelong (and often adverse) side effects." — CMS-2025-1823-1528
Stakeholder Analysis
Stakeholder Categories and Estimated Representation
| Stakeholder Type | Estimated Count | Primary Stance | Notes |
|---|---|---|---|
| Individual citizens / general public | ~4,500 | Oppose (~90%) | Largest single category; spans allies, concerned citizens |
| Parents of transgender youth | ~700–800 | Oppose (>95%) | Highly engaged; personal testimonies dominant mode |
| Healthcare professionals (MDs, nurses, therapists, social workers, psychiatrists, psychologists, pediatricians) | ~800–900 | Oppose (~93%) | Significant professional credential citations |
| Transgender / gender-diverse individuals | ~400–500 | Oppose (>98%) | Direct personal testimony; youth voices present |
| Family members / allies | ~600–700 | Oppose (~95%) | Siblings, grandparents, friends of trans youth |
| Educators (K-12, higher ed, school counselors) | ~200–250 | Oppose (~95%) | Student wellbeing framing |
| Indigenous / tribal advocates | ~200–250 | Oppose (>99%) | Heavily template-coordinated; distinct thematic focus |
| LGBTQ+ advocacy organizations | ~200–300 | Oppose (100%) | Equality California, Garden State Equality, NYCLU, others |
| Medical / professional organizations | ~40–60 | Oppose (>95%) | AMA, AAP, ASRM, Pediatric Endocrine Society, AFSP referenced; CMDA supports rule |
| State / local government entities | ~20–30 | Oppose (~90%) | Oregon Health Authority, County of Los Angeles, state AGs |
| Healthcare systems / hospitals | ~15–25 | Oppose (~95%) | FQHCs, community health centers, hospital associations |
| Academic / research professionals | ~80–100 | Oppose (~90%) | PhDs, researchers in health/psychology |
| Religious / faith organizations | ~30–40 | Mixed | Catholic/Christian medical associations support; Unitarian/progressive faith oppose |
| Legal / civil rights organizations | ~20–30 | Oppose (100%) | Legal Aid Society, NYCLU, QLaw, ACLU (referenced) |
| Conservative / pro-rule individuals | ~700–900 | Support (100%) | Concentrated in Batches 11–18; template-heavy |
| Detransitioner / regret narratives | ~50–80 | Support (~100%) | Small but distinct voice; cited by pro-rule commenters |
Notable Stakeholder-Specific Observations
Healthcare professionals are overwhelmingly in opposition at a rate well exceeding that of the general public. Medical professionals in Batches 1, 8, 9, 16, and 20 provide the most technically sophisticated critiques, citing specific studies, clinical protocols, and professional society guidelines. The near-absence of physician support (only a handful across 11,410 comments) is a significant finding.
Tribal and Indigenous advocates represent the most coherent single-issue campaign in the docket, with a standardized but substantive argument addressing federal trust law, treaty obligations, Medicaid dependency rates among Indigenous children, and Two-Spirit cultural traditions. This campaign appears distinct from the broader LGBTQ+ advocacy coordination.
State and local governments — including at least the Oregon Health Authority, Los Angeles County, and implicitly several state Attorneys General offices (referenced in comments) — filed in opposition, consistent with the 17+ states plus DC that have enacted legal protections for gender-affirming care.
Conservative supporting commenters are disproportionately template-driven. The pro-rule template ("Every child is created male or female"; "Medicaid funds should never be used to mutilate children's bodies") shows lower variation and substantive content compared to opposition comments, though individual pro-rule commenters in Batches 17, 18, and 21 provide more detailed arguments regarding brain development, the Cass Review, and long-term evidence gaps.
Organizational formal submissions (concentrated among the 30 attachment-bearing comments) represent the highest-quality legal and policy analysis in the docket — from the AFSP on suicide evidence, the Legal Aid Society on civil rights, the NYCLU on constitutional claims, PPFA on reproductive/gender healthcare delivery, CWA on worker perspectives, and hospital associations on operational implications.
This report synthesizes analysis of all 11,410 public comments submitted to CMS-2025-1823 across 23 analytical batches covering the full comment record. Quantitative estimates are derived from batch-level counts and should be understood as approximations. All quotes are cited to specific comment IDs as recorded in the batch analyses.